As the only tertiary care medical center in Vermont, the University of Vermont Larner College of Medicine’s Division of Neurosurgery provides comprehensive surgical management of disorders of the brain, spinal cord and peripheral nervous system. Since the division's establishment in 1948, we have been committed to translating leading-edge research into improved patient care.

Residents

Medical students and neurosurgery residents participate in a variety of research activities and provide care and an array of treatment options for patients who have brain and spinal disease. By facilitating critical thinking, we advance the knowledge needed to treat neurologic disorders and enhance the quality of clinical care.


 

Academic and Clinical Excellence

Surgery

As physicians and scientists, the Division of Neurosurgery faculty brings intellectual curiosity, scientific rigor, and fundamental concern to our patients, our trainees, our colleagues, and the communities we serve in northern New England. 

We advance knowledge and innovation, and enhance efficiency through clinical, translational, and biomedical research studies designed to improve the care of patients with neurologic disease. We are dedicated to patient-and family-centric treatment of individuals with neurologic disease, and to developing the next generation of neurosurgical physicians. The UVM Neurosurgery Residency Program if fully accredited by ACGME and committed to training future leaders in the field to be outstanding clinicians, active investigators and experienced educators.


Surgery News

Sprague Study on False-Positive Mammogram Results Featured in HealthDay

September 3, 2024 by Lucy Gardner Carson

(SEPTEMBER 3, 2024) HealthDay featured a study by Brian Sprague, Ph.D., professor of surgery, et al. investigating the effect of false-positive mammogram results on women’s willingness to return for future screening.

UVM Cancer Center member Brian Sprague, Ph.D., professor of surgery, biochemistry, and radiology

(SEPTEMBER 3, 2024) HealthDay featured a study by UVM Cancer Center member Brian Sprague, Ph.D., professor of surgery, biochemistry, and radiology, et al. investigating the effect of false-positive mammogram results on women’s willingness to return for future screening.

The study, “Association Between False-Positive Results and Return to Screening Mammography in the Breast Cancer Surveillance Consortium Cohort,” published recently in the Annals of Internal Medicine, found that false-positive mammogram results are discouraging many women from returning for important follow-up screenings. Researchers say the additional imaging or biopsies performed after a suspicious finding often cause significant anxiety.

False-positive results are common, according to the study, and while most recalled patients do not have breast cancer, researchers say it’s important that they continue screening every one to two years.

Read full story at HealthDay